<div class="entities" style="line-height: 2.5; direction: ltr">Admission Date:  [**2185-11-15**]              Discharge Date:   [**2185-11-24**]<br><br>Date of Birth:  [**2126-1-11**]             Sex:   F<br><br>Service: MEDICINE<br><br>Allergies:<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Keflex
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    /
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Ciprofloxacin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    /
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Ertapenem
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br><br>Attending:[**First Name3 (LF) 943**]<br>Chief Complaint:<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    altered
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mental
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-ADE</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    status
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br><br>Major Surgical or Invasive Procedure:<br>Status post airway intubation (performed at outside hospital,<br>extubated here)<br>PICC placement [**2185-11-17**]<br><br><br>History of Present Illness:<br>Hepatologist:  Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 497**]<br>PCP:  [**Last Name (NamePattern4) **]. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **]<br>.<br>Ms. [**Known lastname 92101**] is a 59yo woman with h/o Hepatitic C Cirrhosis with<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    portal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hypertension
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 s/p TIPS, MELD score 23, who presented to an<br>OSH with 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    altered
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mental
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    status
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.<br>.<br>Her father found her on the morning of admission with her legs<br>hanging over the side of the bed.  She was 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    unresponsive
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.  The<br>family reports that she had been feeling well at home but<br>becoming increasingly 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    confused
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-ADE</span>
</mark>
.  They admit that she often<br>fights against taking 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    lactulose
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, though they feel she is largely<br>compliant with it.  She may have spit out her 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    lactulose
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 dose<br>last night.  Otherwise, ROS significant for some 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    nausea
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.  She<br>has nevertheless been eating and drinking well.  No diarrhea.<br>No 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fevers
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br>.<br>When EMS arrived, her 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    blood
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    sugar
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    was
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    146
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.  She was noted to be<br>incontinent 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    of
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    urine
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.<br>.<br>Upon arrival to [**First Name8 (NamePattern2) **] [**Hospital3 6783**], her VS were 129/60   117   21<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    98
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
% 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    RA
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.  She was intubated because of failure to protect her<br>airway.  Although the lowest recorded temp was 96.2 rectally,<br>she was noted as being 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hypothermic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 and a bair hugger was placed.<br> Labs were notable for K of 6.2 and non-gap 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    acidosis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 with HCO3<br>of 14.  Lactate was elevated at 5.6.  WBC elevated at 16 with<br>Hct and Cr at baseline.  UA significant for large 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    leukocytes
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 and<br>negative nitrites.  CT Head without 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    contrast
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 revealed vague area<br>of low attenuation in the lft frontal region, ? related to small<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    vessel
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ischemia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.  There was no evidence of bleed, mass, or<br>midline shift.  CXR revealed 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    vascular
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    congestion
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.  She was<br>transferred to [**Hospital1 18**] for further care.<br>.<br>Upon arrival to [**Hospital1 18**] MICU, she was intubated.  Further history<br>was obtained via phone call through the patient's son.<br>.<br>ROS:  unable to obtain<br><br><br>Past Medical History:<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Hepatitis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    C
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
, Genotype 1: Diagnosed in [**2185-1-8**] with last<br>VL 263,000 in [**8-/2185**]<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Cirrhosis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 (
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Methotrexate
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and Hepatitis C Induced)<br>Portal 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Hypertension
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Chronic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Kidney
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Disease
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 with baseline Cr 1.8-2.0<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Diastolic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    CHF
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
: Grade I diastolic dysfunction [**7-17**], EF 75%<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Ascites
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Diuretic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Resistant
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Esophageal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Varices
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 per report; however, EGD [**7-/2185**] reports<br>normal esophagus<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Psoriasis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    with
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Arthropathy
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 - s/p 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Methotrexate
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 x 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    15
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Duration</span>
</mark>
 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    years
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Duration</span>
</mark>
 (
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    MTX
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br>d/c in 12.07 when patient developed 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ascites
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 and now uses<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    halobetasol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    cream
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
)<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Anemia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 with baseline Hct 25-30<br>Thyroid nodule 2.2cm identified on ultrasound [**9-16**], needs Bx<br>(has f/u in Thyroid nodule clinic)<br>Admission [**Date range (1) 92102**]:  for elective TIPS, also had 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    UTI
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
<br>Admission [**Date range (1) 92103**]:  for 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hyponatremia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 and 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ARF
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
<br>
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Foot
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-ADE</span>
</mark>
 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    drop
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-ADE</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    from
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 peroneal nerve injury during TIPS procedure (per<br>DC summary)<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Hyponatremia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 with baseline Na 128-130<br>.<br><br><br>Social History:<br>Quit smoking in [**2184**].  No alcohol problems, no drugs.<br>Lives with her son and her father.<br>Uses a cane and walker.<br><br><br>Family History:<br>no FH of liver disease<br><br>Physical Exam:<br>vitals: 97.7   131    122/72    26    100% on 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    AC
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 100%  500/16<br>PEEP +5.<br>Gen: Intubated, not responsive to voice but does move upon touch<br>and withdraw from painful stimuli (not on 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    sedating
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    meds
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
)<br>HEENT: Eyelids closed, eyes are often gazing to the right but<br>she will move her eyes to midline to look toward examiner.<br>Pupils equally reactive, not pinpoint.<br>Face symmetric, mucous membranes moist.<br>Neck: supple, small thyroid nodule in mid-left thyroid.<br>CV: S1, S2, regular tachycardia with I/VI systolic murmur at<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    LUSB
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
, non-radiating.<br>Lungs: clear b/l, no crackles appreciated.<br>Abd: obese with ascites, BS present.  umbilical veins prominent.<br> Soft and she does not flinch with palpation.<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Hepatosplenomegaly
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br>Skin: Flaking, dry skin on scalp and LE b/l.  Large skin tear on<br>right calf.  
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Violaceous
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    plaques
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 on chest and raised subcutaneous<br>areas on her right arm.<br>Ext: 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Erythema
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    of
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    LE
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
, L&gt;R, but not particularly warm.  2+ 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    edema
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
<br>of LE b/l.  Distal pulses +
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 b/l.<br>Neuro: No asterixis when hands are extended at wrists.<br>.<br><br><br>Pertinent Results:<br>[**2185-11-24**] 06:27AM BLOOD WBC-9.8 RBC-2.74* Hgb-8.4* Hct-25.3*<br>MCV-92 MCH-30.7 MCHC-33.3 RDW-17.3* Plt Ct-164<br>[**2185-11-23**] 05:00AM BLOOD WBC-9.2 RBC-2.75* Hgb-8.7* Hct-25.2*<br>MCV-92 MCH-31.7 MCHC-34.6 RDW-17.5* Plt Ct-149*<br>[**2185-11-16**] 06:00AM BLOOD Neuts-77.3* Lymphs-15.9* Monos-5.1<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Eos
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
.5 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Baso
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
-0.2<br>[**2185-11-24**] 06:27AM BLOOD PT-19.9* PTT-46.1* INR(PT)-1.9*<br>[**2185-11-23**] 05:00AM BLOOD PT-21.2* PTT-48.8* INR(PT)-2.0*<br>[**2185-11-24**] 06:27AM BLOOD Glucose-146* UreaN-23* Creat-1.5* Na-129*<br>K-3.7 Cl-103 HCO3-19* AnGap-11<br>[**2185-11-23**] 05:00AM BLOOD Glucose-156* 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    UreaN
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
-22* Creat-1.4* Na-131*<br>K-3.8 Cl-106 HCO3-21* AnGap-8<br>[**2185-11-24**] 06:27AM BLOOD ALT-19 AST-29 LD(LDH)-239 AlkPhos-94<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    TotBili
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
-1.7*<br>[**2185-11-24**] 06:27AM BLOOD 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Albumin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
-2.9* 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Calcium
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
-9.7 Phos-3.1 Mg-1.9<br>.<br>[**2185-11-16**] CT Head without 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    constrast
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
:  No acute intracranial<br>process<br>.<br>[**2185-11-16**] MR [**Name13 (STitle) 430**] and Brain without 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    contrast
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
:  Limited study due<br>to motion artifact. No 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    contrast
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 was administered due to the<br>patient's inability to further cooperate and the marginal renal<br>status. There is no evidence of infarction. The MRA demonstrates<br>a dominant and patent right vertebral artery with a tiny, but<br>apparently patent left vertebral artery, and patent internal<br>carotid arteries bilaterally. The remainder of the study,<br>although limited, demonstrates no evidence of hemorrhage or<br>other abnormalities.<br>.<br>[**2185-11-17**] CT abd and pelvis w/o 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    contrast
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
: 1. No evidence of<br>hemoperitoneum or 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    retroperitoneal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hemorrhage
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.<br>2. 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Cirrhotic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 liver, with signs for portal hypertension with a<br>large amount of 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ascites
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br>3. Consolidation within the lower lobes of the lungs<br>bilaterally, most likely represents 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    atelectasis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
. However,<br>superimposed infection cannot be excluded.<br>4. 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Cholelithiasis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br>5. 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Anasarca
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br>.<br>[**2185-11-22**] Liver, gallbladder u/s: 1. Patent TIPS with abnormally<br>high velocities within the mid and distal aspects of the shunt,<br>similar to the previous exam. Findings remain compatible with<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    TIPS
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 malfunction.<br>2. Limited evaluation of the left and anterior right portal vein<br>although<br>suggestion of abnormal directionality of flow within the left<br>portal vein<br>is compatible with 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    shunt
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    dysfunction
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.<br>3. Cirrhotic liver with moderate-to-severe 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    perihepatic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ascites
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br>and<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    cholelithiasis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br>.<br>[**2185-11-24**] TTE: The left atrium is moderately dilated. Left<br>ventricular wall thickness, cavity size and regional/global<br>systolic function are normal (LVEF 70%). There is no ventricular<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    septal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    defect
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. Right ventricular chamber size and free wall<br>motion are normal. The aortic valve leaflets (3) are mildly<br>thickened but aortic stenosis is not present. No masses or<br>vegetations are seen on the aortic valve. The mitral valve<br>leaflets are mildly thickened. There is no mitral valve<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    prolapse
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
. No mass or vegetation is seen on the mitral valve.<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Trivial
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mitral
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    regurgitation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 is seen. The estimated pulmonary<br>artery systolic pressure is normal. No vegetation/mass is seen<br>on the pulmonic valve. There is no pericardial effusion.<br>.<br>Compared with the findings of the prior study (images reviewed)<br>of [**2185-10-27**], no major change is evident.<br>.<br>IMPRESSION: no obvious vegetations seen<br><br><br>Brief Hospital Course:<br>Ms. [**Known lastname 92101**] is a 59yo woman who presented w/ altered mental<br>status in the setting of 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Hep
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    C
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    cirrhosis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.<br><br># 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Altered
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-ADE</span>
</mark>
 Mental 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Status
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-ADE</span>
</mark>
: Given her hx of hep C cirrhosis and<br>recent TIPs procedure, her 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    AMS
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-ADE</span>
</mark>
 was thought to be most likely due<br>to 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hepatic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    encephalopathyy
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. She was reported to have a hx of<br>poor compliance with 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    lactulose
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 at home.  Of note, she has not<br>had other episodes of 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hepatic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    encephalopathy
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 prior to this.<br>Head CT at OSH was negative.  Given her 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    leukocytosis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-ADE</span>
</mark>
 on<br>admission, 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    infection
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
, particularly 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    SBP
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 or 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pneumonia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
, were also<br>considered. Overdose was also a possibility, although family<br>denies drug use. Upon arrival in the MICU she was started on<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    lactulose
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    rifaximine
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
. She underwent a paracentesis to eval<br>for 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    SBP
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
, which had a negative gram stain and culture. Given her<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    AMS
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
, she was considered high risk for 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    aspiration
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
, and she was<br>started on empiric treatment with 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    vanc
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    /
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    aztreonam
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    /
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    azithromycin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br>(allergic to 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    cipro
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    keflex
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
) for 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    nosocomial
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    or
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    aspiration
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PNA
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br>vs SBP. While there was no known hx of EtOH abuse, 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    thiamine
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    IV
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
<br>was administered. On exam the pt had some focal findings of<br>persistent right-[**Hospital1 **] and downward deviation of her eyes, with<br>inability to track past midline. She had a repeat head CT and an<br>MRI/MRA which were both without evidence of significant<br>pathology. Following extubation and decreased 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    sedation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, her<br>mental status improved and the focal eye findings resolved.<br>While not back at her baseline, pt was awake, alert, and<br>oriented x3 when she was transferred to the floor. Pt seen by<br>Neurology, but had already had significant improvement and no<br>focal findings. On the floor, her mental status continued to<br>improve. At time of discharge, she is back to baseline,<br>conversational, oriented x3 but at times is 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    tearful
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-ADE</span>
</mark>
. She is<br>being discharged on 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Rifaximin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    furosemide
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
.<br>.<br># 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Respiratory
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    failure
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
: Patient was intubated for airway<br>protection at OSH.  Her CXR here suggested a possible aspiration<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pneumonia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
, which could have been [**3-12**] to her AMS.  It is unclear<br>if she received 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    IVF
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 at OSH. She was weaned off of the vent<br>quickly as she required minimal pressure support and had good<br>RSBIs. She was extubated on [**2185-11-17**] was satting well on room air<br>at the time of transfer to the floor. On discharge, she<br>continues to have oxygen saturations in the high 90's on room<br>air.<br>.<br># 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Rash
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
: Pt arrived in the MICU with three skin findings. Bullae,<br>blisters/breakdown, and a  
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    diffuse
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-ADE</span>
</mark>
 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    maculopapular
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-ADE</span>
</mark>
 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    rash
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-ADE</span>
</mark>
 on<br>proximal legs and trunk. Dermatology was consulted. The blisters<br>and bullae were thought to be [**3-12**] 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    trauma
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 in the setting of<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    coagulopathy
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 due to liver disease and thinned skin. Urine<br>Porphobilinogens were checked to rule out porphyria in the<br>setting of Hep C liver disease and were negative. The diffuse<br>
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    maculopapular
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-ADE</span>
</mark>
 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    rash
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-ADE</span>
</mark>
 appeared to be new, and looks more like a<br>
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hypersensitivity
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-ADE</span>
</mark>
 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    reaction
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-ADE</span>
</mark>
, likely to 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ertapenem
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
. Pt has known<br>allergies to 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Keflex
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 ad 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Cipro
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, and had received 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ertapenem
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 at the<br>OSH. She was treated with 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    topical
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    clobetasol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    cream
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 to the 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    rash
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
<br>on abdomen and lower extremities (avoiding folds), and<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hydrocortisone
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    2
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    5
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    %
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    cream
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 to 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    rash
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 in folds of abdomen and groin.<br>Also, the bullae over time evolved into 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ulcerations
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-ADE</span>
</mark>
 on the pt's<br>legs, arms and left shoulder which were treated with wound care<br>as recommended by our wound care team and plastics.<br>.<br># 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Cirrhosis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 [**3-12**] 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Hep
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 C: Pt was treated as described above with<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    lactulose
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    rifaximine
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 as well as a 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PPI
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, and was followed by<br>Hepatology.  She had a RUQ ultrasound on [**11-16**] and again on [**11-23**]<br>which showed her TIPS was patent. She should have a repeats TIPS<br>ultrasound in 1 month. She had a 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    5L
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 paracentesis on [**11-20**] which<br>was negative for increased WBC and culture was sterile.<br>.<br># 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    VRE
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
: Pt had blood culture [**11-16**] which grew 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    VRE
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 sensitive to<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    daptomycin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    linezolid
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 in [**2-11**] bottles. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Daptomycin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 was started<br>on [**11-17**].  ID was consulted in house. TTE showed no vegetations<br>on [**11-24**].  The pt should be continued on 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    IV
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    daptomycin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 to<br>complete a 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    14
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Duration</span>
</mark>
 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    day
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Duration</span>
</mark>
 course on [**2185-12-2**].<br>.<br># 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Sinus
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    tachycardia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
: Pt was likely intravascularly dry on<br>admission given Hct above baseline, poor urine output, and<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    tachycardia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 above baseline, although some level of tachyardia<br>appears to be chronic in her.  Also may be exacerbated by acute<br>illness. She received 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    albumin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    25g
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    in
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    500cc
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    NS
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    x2
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 and her HR and<br>urine output were followed. Her 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    diuretics
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 were held until the<br>next morning. At discharge, her HR remains in the 80's to 90's.<br>.<br># 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Chronic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    diastolic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    heart
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    failure
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
: Appeared hypovolemic<br>admission, her 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    diuretics
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 were held as above. Her 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    diuretics
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 were<br>gradually restarted on the floor. She is not accumulating<br>ascited at the time of discharge.<br>.<br># 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Chronic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Kidney
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Disease
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
:  baseline Cr 1.8-2.0, Cr on discharge<br>1.5, urine output initially poor on admission, but improved<br>after 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fluid
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 challenge.<br>.<br># 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Thyroid
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    nodule
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
: Should be followed up as outpatient.<br>.<br># 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Hyponatremia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
: Pt has chronic hyponatremia seen on past<br>admission with baseline 128-130. As 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    diuretics
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 were increased,<br>her 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    sodium
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 gradually decreased to 129 on day of discharge.<br>Treatment ongoing for this condition should include ongoing<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fluid
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    restriction
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 to approximately 1500cc/day.<br>.<br># 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Hypercalcemia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
: Pt had transient hypercalcemia to 10.8 this<br>admission thought to be [**3-12**] 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Calcium
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    vitamin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    D
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 use at home.<br>These were stopped and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Ca
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 is now 9.9 at time of discharge.<br>Recommend not restarting these medications at this time.<br>.<br># [**Name (NI) 1867**] Pt with 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    thrombocytopenia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-ADE</span>
</mark>
 this admission<br>thought [**3-12**] 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    chronic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    liver
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    disease
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. Plt at discharge are 164.<br><br><br>Medications on Admission:<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Metoclopramide
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    5mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    TID
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Pantoprazole
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    40
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Clobetasol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    0
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    05
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    %
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Cream
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 [**Hospital1 **]<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Ergocalciferol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Vitamin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    D2
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    50
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ,
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    000
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    unit
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    QWednesday
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Calcium
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Cholecalciferol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    D3
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    500
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ,
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    250
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    400
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    unit
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 [**Hospital1 **]<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Nystatin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    100
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ,
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    000
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    unit
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    /
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mL
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    5ml
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    QID
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Lactulose
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    30ml
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 [**Hospital1 **]<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Furosemide
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    40
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Spironolactone
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    25
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br>.<br><br><br>Discharge Medications:<br>1. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Heparin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Flush
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 (
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    10
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    units
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    /
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ml
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>

<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    2
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mL
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    IV
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PRN
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    line
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    flush
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br>PICC, 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    heparin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 dependent: Flush with 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    10mL
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Normal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Saline
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 followed<br>by 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Heparin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 as above 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
 and 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PRN
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
 per lumen.<br>2. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Daptomycin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    500
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Recon
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Soln
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Four
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Hundred
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    400
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
<br>
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Intravenous
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Q48H
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
 (
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    every
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    48
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hours
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
): Please continue 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    for
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Duration</span>
</mark>
 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    9
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Duration</span>
</mark>
 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    days
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Duration</span>
</mark>
.<br>Please NOTE: patient has changing renal function. Currently GFR<br>is less than 50, so should dose 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    q48
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hours
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
. If GFR&gt;50, please<br>change to 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    q24
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hour
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
 dosing.<br>3. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Clobetasol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    0
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    05
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    %
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Cream
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
) 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Appl
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Topical
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 [**Hospital1 **] (2<br>times 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    a
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    day
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
) as 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    needed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
 for 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    psoriasis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br>4. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Furosemide
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    40
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    DAILY
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 (
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
).<br><br>5. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Spironolactone
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    25
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    DAILY
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br>(
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
).<br>6. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Lactulose
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    10
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    gram
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    /
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    15
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mL
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Syrup
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Thirty
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    30
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ML
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    twice
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    a
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
<br>day.<br>7. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Metoclopramide
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    10
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    TID
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
 (3<br>times 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    a
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    day
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
).<br>8. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Nystatin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    100
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ,
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    000
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    unit
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    /
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mL
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Suspension
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Five
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    5
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ML
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    QID
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br>(
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    4
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    times
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    a
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    day
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
).<br>9. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Rifaximin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    200
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Two
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    2
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    TID
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 (3 times a<br>day).<br>10. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Hydrocortisone
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    2
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    5
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    %
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Cream
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
) 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Appl
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Rectal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 [**Hospital1 **] (2<br>times 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    a
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    day
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
).<br>11. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Thiamine
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    HCl
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    100
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    DAILY
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br>(
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
).<br>12. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Pantoprazole
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    40
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Form</span>
</mark>

<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ,
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Delayed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Release
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>
 (E.C.) Sig: One<br>(
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
) 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Form</span>
</mark>

<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ,
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Delayed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Release
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>
 (E.C.) 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Q24H
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
 (
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    every
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    24
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hours
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
).<br>13. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Acetaminophen
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    325
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Q6H
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br>(
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    every
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    6
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hours
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>

<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    as
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    needed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
 for 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pain
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br><br><br>Discharge Disposition:<br>Extended Care<br><br>Discharge Diagnosis:<br>Primary:<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Vancomycin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Resistant
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Enterococcus
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Bacteremia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Encephalopathy
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Traumatic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Skin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Rash
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-ADE</span>
</mark>
<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Hyponatremia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
<br><br>Secondary:<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Hepatitis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    C
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Cirrhosis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Chronic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Kidney
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Disease
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br><br><br>Discharge Condition:<br>Afebrile, stable, ambulatory.<br><br><br>Discharge Instructions:<br>You were admitted after you were found passed out at home. This<br>was likely due to 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    encephalopathy
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 which cleared with 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    lactulose
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
,<br>and an 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    infection
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 that was found in your blood. You will continue<br>on an 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    antibiotic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Daptomycin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    intravenously
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 for a total of 14<br>days, finishing on [**12-2**]. Please be sure to renally dose<br>this medication: 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    once
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
 if 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    GFR
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    &gt;
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    50
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 or 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    once
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    every
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    other
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    day
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
 if<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    GFR
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    &lt;
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    50
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.<br>.<br>Continuing issues include 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hyponatremia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
, which should be managed<br>initially with 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fluid
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    restriction
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. She has had chronic<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hyponatremia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 with baseline 128-130 on previous admission here.<br>Please monitor sodium levels while at [**Hospital1 **].<br>.<br>Her course has also been complicated by easy bruising and<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    blistering
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 which has necessitated a dermatology consult. It was<br>felt these were traumatically induced. They are being cared for<br>currently with wound care.<br>.<br>Of note, the patient was 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hypercalcemic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-ADE</span>
</mark>
, and found to have<br>elevated 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PTH
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-ADE</span>
</mark>
 level. She had been taking 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ergocalciferol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    cholecalciferol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 both of which were stopped, and the 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    calcium
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br>normalized. Please continue to hold these medications, to be<br>restarted at the discretion of her primary care physician and<br>[**Hospital1 **] physician.<br>.<br><br>Followup Instructions:<br>Provider: [**Name10 (NameIs) **] THYROID NODULE CENTER Phone:[**Telephone/Fax (1) 26555**]<br>Date/Time:[**2185-12-1**] 10:30<br>Provider: [**Name10 (NameIs) **] [**Hospital 1389**] CLINIC Phone:[**Telephone/Fax (1) 673**]<br>Date/Time:[**2185-12-7**] 8:40<br><br><br><br>Completed by:[**2185-11-24**]</div>